ストックスクリーナーアプリを入手
35.52
0.91%
0.32
アフターアワーズ：
35.52
Collegium Pharmaceutical Inc (COLL) 最新ニュース
Winners And Losers Of Q1: Collegium Pharmaceutical (NASDAQ:COLL) Vs The Rest Of The Branded Pharmaceuticals Stocks - Yahoo Finance
Collegium Pharmaceutical Inc (COLL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Collegium Pharmaceutical Inc (COLL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Collegium Pharmaceutical, Inc. Revenue Breakdown – FWB:354 - TradingView
Collegium Pharmaceutical Inc (COLL) Institutional Confidence - TradingKey
Collegium Pharmaceutical, Inc. Revenue Breakdown – BOATS:COLL - TradingView
Collegium Pharmaceutical Inc (COLL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Collegium Pharmaceutical stock gains 2.46% as CollegiumPharma schedules Q2 results call for August 6 - Traders Union
Collegium's Aug. 6 results will be followed by an 8 a.m. webcast - Stock Titan
Is Collegium Pharmaceutical Inc (COLL) a Bargain After 3.1% Drop? GF Value Says Undervalued - GuruFocus
Collegium Pharmaceutical Inc. (COLL) Q1 2024 Earnings ReportResults, Call & Slides - TipRanks
Pharma Company Moving Headquarters From Suburbs To Downtown Boston - Bisnow
Collegium Pharmaceutical to relocate headquarters to Boston - Investing.com
DivcoWest Welcomes Collegium Pharmaceutical to One Lincoln - Business Wire
Collegium Pharmaceutical to relocate headquarters to Boston By Investing.com - Investing.com Canada
After More Than 20 Years, Collegium Plans Boston Headquarters Move - Stock Titan
Collegium Pharmaceutical Inc. (COLL) Q2 2023 Earnings ReportResults, Call & Slides - TipRanks
Collegium Pharmaceutical Announces New Corporate Headquarters at One Lincoln in Boston - Sahm
Is Collegium Pharmaceutical (COLL) Still Undervalued As Its Growth Narrative Holds Up? - Yahoo Finance Singapore
Collegium Pharmaceutical Q1 2026 Earnings: EPS Surpasses Estimates by 8.43%Special Dividend Alert - dars.gov.et
COLL5756983 Bond Coupon Profile — Rate & Payments - TradingView
Collegium Pharmaceutical (COLL) Stock Looks Fairly Valued With Strong Returns But Mixed Earnings## - simplywall.st
Form 144 COLLEGIUM PHARMACEUTICAL For: 17 July By Investing.com - Investing.com Nigeria
(COLL) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Planned sale of 13,920 COLL shares follows earlier 8,095-share disposal (COLL) - Stock Titan
enGene names Michael Heffernan board chairman as Richard Glickman steps down - Bitget
ETFs Investing in Collegium Pharmaceutical, Inc. Stocks - TradingView
COLL5756983 Bond Risk Profile - TradingView
COLL5756983 Bond Profile — Key Metrics - TradingView
US19459JAC8 Bond Coupon Profile — Rate & Payments - TradingView
US19459JAC8 Bond Risk Profile - TradingView
[144] COLLEGIUM PHARMACEUTICAL, INC SEC Filing - Stock Titan
Enterprise value to EBITDA forward of Collegium Pharmaceutical, Inc. – NASDAQ:COLL - TradingView
Collegium Pharmaceutical (COLL) Draws Fresh Valuation Attention, Is It Still A Bargain? - simplywall.st
4 defensive stocks to take refuge in as tech sell-off continues - MSN
Collegium Pharmaceutical stock gains 12% in three months: Here's why - MSN
Price to earnings forward of Collegium Pharmaceutical, Inc. – NASDAQ:COLL - TradingView
Should Value Investors Buy Collegium Pharmaceutical (COLL) Stock? - Yahoo Finance
Price to book forward of Collegium Pharmaceutical, Inc. – NASDAQ:COLL - TradingView
New Strong Buy Stocks for July 6th - Yahoo Finance Singapore
Collegium Pharmaceutical Q1 2026 slides: ADHD growth drives earnings beat - Investing.com
Price to earnings forward of Collegium Pharmaceutical, Inc. – FWB:354 - TradingView
Enterprise value to EBITDA forward of Collegium Pharmaceutical, Inc. – FWB:354 - TradingView
Price to sales forward of Collegium Pharmaceutical, Inc. – FWB:354 - TradingView
COLLCollegium Pharmaceutical Inc Website Traffic and Mobile Apps Usage - Finviz
Is Collegium Pharmaceutical (COLL) A Bargain On Its Azstarys Deal And 2026 Guidance? - simplywall.st
Collegium Pharmaceutical (COLL) Gains 3.2% as Stock Approaches Key ResistanceTurnaround Stocks - dars.gov.et
2 Profitable Stocks to Keep an Eye On and 1 We Brush Off - Yahoo Finance
Collegium Pharmaceutical Stock Gains 12% in Three Months: Here's Why - The Globe and Mail
Barclays Maintains Collegium Pharmaceutical(COLL.US) With Buy Rating, Maintains Target Price $56 - Moomoo
Collegium (NASDAQ: COLL) details $655.6M AZSTARYS acquisition terms - Stock Titan
Collegium Pharmaceutical, Inc. Actuals & Estimates (NASDAQ:COLL) - TradingView
COLL Forecast — Price Target — Prediction for 2027 - TradingView
How (COLL) Movements Inform Risk Allocation Models - Stock Traders Daily
Collegium Pharmaceutical Inc (COLL) Valuation: PE, PB & Fair Value Analysis - TradingKey
Collegium Pharmaceutical stock rises toward upper weekly range amid short-term recovery - Traders Union
Are Investors Undervaluing Collegium Pharmaceutical (COLL) Right Now? - Yahoo Finance
Did Collegium Pharmaceutical’s Profitability Surge and Efficiency Gains Just Shift COLL’s Investment Narrative? - simplywall.st
0.30%
2.01%
大文字化:
|
ボリューム (24 時間):